On the public citation graph

The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy

0 signed · 385 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ijc.25979openalex-snapshot
High expression of indoleamine 2,3‐dioxygenase in the tumour is associated with medullary features and favourable outcome in basal‐like breast carcinoma
inferredcites →https://doi.org/10.1002/ijc.29481openalex-snapshot
Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients
inferredcites →https://doi.org/10.1002/path.4287openalex-snapshot
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
inferredcites →https://doi.org/10.1006/cyto.1999.0661openalex-snapshot
TRANSCRIPTIONAL ACTIVATION OF INDOLEAMINE DIOXYGENASE BY INTERLEUKIN 1 AND TUMOR NECROSIS FACTOR α IN INTERFERON-TREATED EPITHELIAL CELLS
inferredcites →https://doi.org/10.1007/s00262-013-1393-yopenalex-snapshot
Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry
inferredcites →https://doi.org/10.1007/s00277-010-1093-zopenalex-snapshot
Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP
inferredcites →https://doi.org/10.1007/s00428-012-1340-xopenalex-snapshot
Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma
inferredcites →https://doi.org/10.1007/s00432-008-0395-1openalex-snapshot
Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s10120-014-0440-5openalex-snapshot
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer
inferredcites →https://doi.org/10.1007/s10585-009-9290-7openalex-snapshot
Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma
inferredcites →https://doi.org/10.1007/s10620-013-2837-0openalex-snapshot
The Correlation Between the Subsets of Tumor Infiltrating Memory T Cells and the Expression of Indoleamine 2,3-Dioxygenase in Gastric Cancer
inferredcites →https://doi.org/10.1016/j.amjoto.2014.08.009openalex-snapshot
FoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients
inferredcites →https://doi.org/10.1016/j.bbi.2014.06.200openalex-snapshot
Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation
inferredcites →https://doi.org/10.1016/j.clml.2018.12.005openalex-snapshot
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes
inferredcites →https://doi.org/10.1016/j.ejca.2011.09.007openalex-snapshot
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients
inferredcites →https://doi.org/10.1016/j.gene.2007.04.010openalex-snapshot
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
inferredcites →https://doi.org/10.1016/j.immuni.2005.03.013openalex-snapshot
GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase
inferredcites →https://doi.org/10.1016/j.jcyt.2016.05.010openalex-snapshot
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab
inferredcites →https://doi.org/10.1016/j.jocn.2015.06.018openalex-snapshot
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy
inferredcites →https://doi.org/10.1016/j.leukres.2008.06.014openalex-snapshot
Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients’ sera by HPLC and is inducible by IFN-γ
inferredcites →https://doi.org/10.1016/j.leukres.2013.02.001openalex-snapshot
Metabolites of tryptophan catabolism are elevated in sera of patients with myelodysplastic syndromes and inhibit hematopoietic progenitor amplification
inferredcites →https://doi.org/10.1016/j.lungcan.2009.05.001openalex-snapshot
Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer
inferredcites →https://doi.org/10.1016/j.oraloncology.2011.03.007openalex-snapshot
Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas
inferredcites →https://doi.org/10.1016/j.ygyno.2009.07.015openalex-snapshot
Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma
inferredcites →https://doi.org/10.1016/j.ygyno.2010.02.028openalex-snapshot
Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy
inferredcites →https://doi.org/10.1016/j.ygyno.2011.04.050openalex-snapshot
Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests
inferredcites →https://doi.org/10.1016/j.ygyno.2011.12.416openalex-snapshot
Status of cellular immunity lacks prognostic significance in vulvar squamous carcinoma
inferredcites →https://doi.org/10.1016/j.ygyno.2012.05.034openalex-snapshot
Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma
inferredcites →https://doi.org/10.1016/s0021-9258(19)77982-4openalex-snapshot
Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity.
inferredcites →https://doi.org/10.1038/bjc.2011.513openalex-snapshot
Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
inferredcites →https://doi.org/10.1038/ni846openalex-snapshot
CTLA-4–Ig regulates tryptophan catabolism in vivo
inferredcites →https://doi.org/10.1038/nm1196openalex-snapshot
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
inferredcites →https://doi.org/10.1038/nm934openalex-snapshot
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
inferredcites →https://doi.org/10.1038/nri1919openalex-snapshot
Tumour–induced immune modulation of sentinel lymph nodes
inferredcites →https://doi.org/10.1038/onc.2008.35openalex-snapshot
Immune escape as a fundamental trait of cancer: focus on IDO
inferredcites →https://doi.org/10.1038/sj.bjc.6600336openalex-snapshot
Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer
inferredcites →https://doi.org/10.1038/sj.bjc.6603477openalex-snapshot
Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer
inferredcites →https://doi.org/10.1038/sj.mp.4000995openalex-snapshot
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy
inferredcites →https://doi.org/10.1042/bst0361120openalex-snapshot
Exploring the mechanism of tryptophan 2,3-dioxygenase
inferredcites →https://doi.org/10.1042/cs20140392openalex-snapshot
Role of indoleamine 2,3-dioxygenase in health and disease
inferredcites →https://doi.org/10.1056/nejmc1509660openalex-snapshot
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1003466openalex-snapshot
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1412082openalex-snapshot
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
inferredcites →https://doi.org/10.1056/nejmoa1503093openalex-snapshot
Pembrolizumab versus Ipilimumab in Advanced Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1504030openalex-snapshot
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1507643openalex-snapshot
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1510665openalex-snapshot
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
inferredcites →https://doi.org/10.1073/pnas.1014465107openalex-snapshot
Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism
inferredcites →https://doi.org/10.1073/pnas.1113873109openalex-snapshot
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
inferredcites →https://doi.org/10.1073/pnas.85.4.1242openalex-snapshot
Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma.
inferredcites →https://doi.org/10.1074/jbc.271.29.17247openalex-snapshot
Cooperative Role of Interferon Regulatory Factor 1 and p91 (STAT1) Response Elements in Interferon-γ-inducible Expression of Human Indoleamine 2,3-Dioxygenase Gene
inferredcites →https://doi.org/10.1084/jem.20130066openalex-snapshot
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
inferredcites →https://doi.org/10.1086/515347openalex-snapshot
Interferon‐γ‐Induced Activation of Indoleamine 2,3‐Dioxygenase in Cord Blood Monocyte‐Derived Macrophages Inhibits the Growth of Group B Streptococci
inferredcites →https://doi.org/10.1097/cmr.0000000000000171openalex-snapshot
Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients
inferredcites →https://doi.org/10.1111/bjd.13100openalex-snapshot
Peritumoral indoleamine 2,3‐dioxygenase expression in melanoma: an early marker of resistance to immune control?
inferredcites →https://doi.org/10.1111/j.1349-7006.2011.02094.xopenalex-snapshot
Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer
inferredcites →https://doi.org/10.1111/j.1365-2567.2009.03054.xopenalex-snapshot
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system
inferredcites →https://doi.org/10.1111/j.1398-9995.2008.01809.xopenalex-snapshot
Tryptophan catabolites regulate mucosal sensitization to ovalbumin in respiratory airways
inferredcites →https://doi.org/10.1111/j.1440-1746.2003.03259.xopenalex-snapshot
Immunoactivative role of indoleamine 2,3‐dioxygenase in human hepatocellular carcinoma
inferredcites →https://doi.org/10.1111/j.1600-0609.2009.01393.xopenalex-snapshot
Serum concentration of L ‐kynurenine predicts the clinical outcome of patients with diffuse large B‐cell lymphoma treated with R‐CHOP
inferredcites →https://doi.org/10.1126/science.1073514openalex-snapshot
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
inferredcites →https://doi.org/10.1126/science.281.5380.1191openalex-snapshot
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
inferredcites →https://doi.org/10.1126/scitranslmed.3006504openalex-snapshot
Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T Cells
inferredcites →https://doi.org/10.1136/gut.2009.185108openalex-snapshot
Gut CD103 + dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction
inferredcites →https://doi.org/10.1155/2011/384726openalex-snapshot
Involvement of Indoleamine 2,3-Dioxygenase in Impairing Tumor-Infiltrating CD8+T-Cell Functions in Esophageal Squamous Cell Carcinoma
inferredcites →https://doi.org/10.1155/2011/469135openalex-snapshot
Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T CellsIn Situand Lymph Node Metastasis
inferredcites →https://doi.org/10.1158/0008-5472.can-07-1872openalex-snapshot
Novel Tryptophan Catabolic Enzyme IDO2 Is the Preferred Biochemical Target of the Antitumor Indoleamine 2,3-Dioxygenase Inhibitory Compound d -1-Methyl-Tryptophan
inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-2671openalex-snapshot
Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells
inferredcites →https://doi.org/10.1158/1078-0432.ccr-05-1966openalex-snapshot
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
inferredcites →https://doi.org/10.1158/1078-0432.ccr-07-0942openalex-snapshot
Expression of Indoleamine 2,3-Dioxygenase in Tumor Endothelial Cells Correlates with Long-term Survival of Patients with Renal Cell Carcinoma
inferredcites →https://doi.org/10.1158/1078-0432.ccr-07-4144openalex-snapshot
Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-1988openalex-snapshot
A Novel Cancer Therapy by Skin Delivery of Indoleamine 2,3-Dioxygenase siRNA
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-2130openalex-snapshot
IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
inferredcites →https://doi.org/10.1158/1078-0432.ccr-13-1560openalex-snapshot
Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
inferredcites →https://doi.org/10.1158/2326-6066.cir-14-0137openalex-snapshot
Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues
inferredcites →https://doi.org/10.1159/000096906openalex-snapshot
Decreased Serum Tryptophan Concentration Predicts Poor Prognosis in Malignant Melanoma Patients
inferredcites →https://doi.org/10.1164/rccm.200509-1413ocopenalex-snapshot
Novel Action of Indoleamine 2,3-Dioxygenase Attenuating Acute Lung Allograft Injury
inferredcites →https://doi.org/10.1165/rcmb.2003-0268ocopenalex-snapshot
CDllc + Cells Modulate Pulmonary Immune Responses by Production of Indoleamine 2,3-Dioxygenase
inferredcites →https://doi.org/10.1172/jci200421583openalex-snapshot
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
inferredcites →https://doi.org/10.1172/jci21583openalex-snapshot
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
inferredcites →https://doi.org/10.1172/jci28801openalex-snapshot
CD40Ig treatment results in allograft acceptance mediated by CD8+CD45RClow T cells, IFN-γ, and indoleamine 2,3-dioxygenase
inferredcites →https://doi.org/10.1177/039463200802100205openalex-snapshot
Inflamed Intestinal Mucosa Features a Specific Epithelial Expression Pattern of Indoleamine 2,3-Dioxygenase
inferredcites →https://doi.org/10.1182/blood-2007-10-116111openalex-snapshot
Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells
inferredcites →https://doi.org/10.1182/blood.v124.21.4653.4653openalex-snapshot
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes
inferredcites →https://doi.org/10.1186/1471-2407-14-335openalex-snapshot
Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study
inferredcites →https://doi.org/10.1186/1479-5876-7-71openalex-snapshot
The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
inferredcites →https://doi.org/10.1186/s12967-014-0376-xopenalex-snapshot
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
inferredcites →https://doi.org/10.1186/s13058-014-0410-1openalex-snapshot
Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression
inferredcites →https://doi.org/10.1186/s40425-015-0094-9openalex-snapshot
Targeting the indoleamine 2,3-dioxygenase pathway in cancer
inferredcites →https://doi.org/10.1200/jco.2009.27.15_suppl.3004openalex-snapshot
Overcoming tumor antigen anergy in human malignancies using the novel indeolamine 2,3-dioxygenase (IDO) enzyme inhibitor, 1-methyl-D-tryptophan (1MT)
inferredcites →https://doi.org/10.1200/jco.2013.31.15_suppl.3025openalex-snapshot
Phase I study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the oral inhibitor of indoleamine 2,3-dioxygenase (IDO1) INCB024360 in patients (pts) with advanced malignancies.
inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.3010openalex-snapshot
Preliminary results from a phase 1/2 study of INCB024360 combined with ipilimumab (ipi) in patients (pts) with melanoma.
inferredcites →https://doi.org/10.1210/jc.2013-3351openalex-snapshot
Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment
inferredcites →https://doi.org/10.1227/neu.0b013e31828cf945openalex-snapshot
Expression of Indoleamine 2,3-Dioxygenase and Correlation With Pathological Malignancy in Gliomas
inferredcites →https://doi.org/10.1369/jhc.2009.953604openalex-snapshot
Indoleamine 2,3-Dioxygenase Tissue Distribution and Cellular Localization in Mice: Implications for Its Biological Functions
inferredcites →https://doi.org/10.1593/neo.04658openalex-snapshot
Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non Small Cell Lung Cancer
inferredcites →https://doi.org/10.18632/oncotarget.1504openalex-snapshot
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia
inferredcites →https://doi.org/10.18632/oncotarget.2357openalex-snapshot
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors
inferredcites →https://doi.org/10.2174/138920007780362509openalex-snapshot
The Human Indoleamine 2,3-Dioxygenase Gene and Related Human Genes
inferredcites →https://doi.org/10.3109/10428194.2013.804917openalex-snapshot
Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration
inferredcites →https://doi.org/10.3109/10428194.2015.1041388openalex-snapshot
High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia
inferredcites →https://doi.org/10.3109/10428194.2015.1117610openalex-snapshot
An increase in indoleamine 2,3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone
inferredcites →https://doi.org/10.3324/haematol.13112openalex-snapshot
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
inferredcites →https://doi.org/10.3324/haematol.13113openalex-snapshot
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
inferredcites →https://doi.org/10.3748/wjg.v22.i13.3592openalex-snapshot
Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma
inferredcites →https://doi.org/10.3892/or.17.6.1333openalex-snapshot
Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer
inferredcites →https://doi.org/10.3969/j.issn.1672-7347.2012.07.001openalex-snapshot
Indoleamine-pyrrole 2,3-dioxygenase might be a prognostic biomarker for patients with renal cell carcinoma.
inferredcites →https://doi.org/10.4049/jimmunol.0903670openalex-snapshot
An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
inferredcites →https://doi.org/10.4049/jimmunol.171.4.1652openalex-snapshot
Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion
inferredcites →https://doi.org/10.4161/2162402x.2014.981457openalex-snapshot
Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival
inferredcites →https://doi.org/10.4161/2162402x.2014.982382openalex-snapshot
Characterization of thein vivoimmune network of IDO, tryptophan metabolism, PD-L1, andCTLA-4in circulating immune cells in melanoma
inferredcites →https://doi.org/10.4161/2162402x.2014.983770openalex-snapshot
Indoleamine 2,3-dioxygenase vaccination
inferredcites →https://doi.org/10.4161/cbt.6.8.4446openalex-snapshot
Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer
inferredcites →https://doi.org/10.4161/cc.8.12.8745openalex-snapshot
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival
inferredcites →https://doi.org/10.4161/onci.23428openalex-snapshot
Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer
inferredcites →https://doi.org/10.5114/pjp.2015.57249openalex-snapshot
The prognostic significance of indoleamine-2,3-dioxygenase and the receptors for transforming growth factor β and interferon γ in metastatic lymph nodes in malignant melanoma

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4878506openalex-extracted
Exploration of the Mechanisms of Dendrobium Huoshanense for Treating Ovarian Cancer Based on a Comprehensive Approach
inferred← citeshttps://doi.org/10.1002/9781119126843.ch5openalex-snapshot
Immunotherapies for Cancer
inferred← citeshttps://doi.org/10.1002/adhm.202504988openalex-snapshot
Modification‐Driven Nanocarriers: Ovarian Cancer Cell Membrane– Camouflaged Indoximod/Doxorubicin Co‐Delivery Systems for Synergistic Immunochemotherapy
inferred← citeshttps://doi.org/10.1002/biof.1826openalex-snapshot
Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic/gluconeogenic pathway through downregulation of TPI1
inferred← citeshttps://doi.org/10.1002/bmm2.70062openalex-snapshot
Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/cam4.70703openalex-snapshot
The Kynurenine Pathway and Indole Pathway in Tryptophan Metabolism Influence Tumor Progression
inferred← citeshttps://doi.org/10.1002/cbic.201700560openalex-snapshot
New 4‐Amino‐1,2,3‐Triazole Inhibitors of Indoleamine 2,3‐Dioxygenase Form a Long‐Lived Complex with the Enzyme and Display Exquisite Cellular Potency
inferred← citeshttps://doi.org/10.1002/cbic.202500134openalex-snapshot
Boron‐Based Functionalities Enhance the Potency of 2,5‐Dimethylfuran‐Based IDO1 Inhibitors
inferred← citeshttps://doi.org/10.1002/cmdc.202100253openalex-snapshot
Structural Basis of Selective Human Indoleamine‐2,3‐dioxygenase 1 (hIDO1) Inhibition
inferred← citeshttps://doi.org/10.1002/cncy.22172openalex-snapshot
Indoleamine 2,3‐dioxygenase and tryptophan 2,3‐dioxygenase expression in HPV infection, SILs, and cervical cancer
inferred← citeshttps://doi.org/10.1002/hon.3108openalex-snapshot
Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients
inferred← citeshttps://doi.org/10.1002/ijc.31417openalex-snapshot
1‐L‐MT, an IDO inhibitor, prevented colitis‐associated cancer by inducing CDC20 inhibition‐mediated mitotic death of colon cancer cells
inferred← citeshttps://doi.org/10.1002/iub.2180openalex-snapshot
Cell transfer‐based immunotherapies in cancer: A review
inferred← citeshttps://doi.org/10.1002/jcb.30402openalex-snapshot
The therapeutic potential of immunotherapy in the treatment of breast cancer: Rational strategies and recent progress
inferred← citeshttps://doi.org/10.1007/978-3-030-05070-2_59openalex-snapshot
Novel Immunotherapies and Novel Combinations of Immunotherapy for Metastatic Melanoma
inferred← citeshttps://doi.org/10.1007/978-3-030-49844-3_16openalex-snapshot
Metabolic Stress and Immunity: Nutrient-Sensing Kinases and Tryptophan Metabolism
inferred← citeshttps://doi.org/10.1007/978-3-030-50287-4_31openalex-snapshot
Hurdles in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_72-1openalex-snapshot
Indoleamine 2,3-Dioxygenase (IDO) and Cancerous Cells
inferred← citeshttps://doi.org/10.1007/978-3-031-97242-3_3openalex-snapshot
Recent Advancements in Immunotherapy for the Treatment of Metastatic Breast Cancer
inferred← citeshttps://doi.org/10.1007/978-3-032-00759-9_72openalex-snapshot
Indoleamine 2,3-Dioxygenase (IDO) and Cancerous Cells
inferred← citeshttps://doi.org/10.1007/978-3-319-46029-1_59-1openalex-snapshot
Novel Immunotherapies and Novel Combinations of Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-981-99-7141-1_9openalex-snapshot
IDO and TGF-β Inhibitors for the Treatment of Lung Cancer
inferred← citeshttps://doi.org/10.1007/s00105-018-4124-7openalex-snapshot
Aktuelle Aspekte in der Prognose des fortgeschrittenen Melanoms
inferred← citeshttps://doi.org/10.1007/s00281-018-0695-8openalex-snapshot
The T-win® technology: immune-modulating vaccines
inferred← citeshttps://doi.org/10.1007/s00281-020-00798-wopenalex-snapshot
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
inferred← citeshttps://doi.org/10.1007/s00428-018-2483-1openalex-snapshot
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications
inferred← citeshttps://doi.org/10.1007/s00432-020-03390-9openalex-snapshot
Association of PD-L1 and IDO1 expression with JAK–STAT pathway activation in soft-tissue leiomyosarcoma
inferred← citeshttps://doi.org/10.1007/s00432-022-04277-7openalex-snapshot
IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma
inferred← citeshttps://doi.org/10.1007/s10822-021-00386-6openalex-snapshot
Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays
inferred← citeshttps://doi.org/10.1007/s11051-022-05496-2openalex-snapshot
Research progress of photothermal-mediated immunotherapy in the prevention of tumor recurrence and metastases
inferred← citeshttps://doi.org/10.1007/s11060-019-03198-9openalex-snapshot
Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas
inferred← citeshttps://doi.org/10.1007/s11307-019-01327-4openalex-snapshot
Evaluation of l-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
inferred← citeshttps://doi.org/10.1007/s11912-018-0697-7openalex-snapshot
Combination Immunotherapy in Non-small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1007/s12274-022-4597-7openalex-snapshot
Tumor and dendritic cell dual-targeting nanocarriers maximize the therapeutic potential of IDO1 inhibitor in vivo
inferred← citeshttps://doi.org/10.1007/s12282-024-01654-7openalex-snapshot
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy
inferred← citeshttps://doi.org/10.1007/s40259-018-0291-4openalex-snapshot
Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1016/bs.acr.2019.03.006openalex-snapshot
Immunotherapy in breast cancer: Current status and future directions
inferred← citeshttps://doi.org/10.1016/j.bbcan.2019.06.003openalex-snapshot
Fibroblasts in cancer: Defining target structures for therapeutic intervention
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2021.121018openalex-snapshot
Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.103356openalex-snapshot
Design, synthesis and biological evaluation of bicyclic carboxylic acid derivatives as IDO1 inhibitors
inferred← citeshttps://doi.org/10.1016/j.biopha.2020.111180openalex-snapshot
The protective effect of 1-methyltryptophan isomers in renal ischemia-reperfusion injury is not exclusively dependent on indolamine 2,3-dioxygenase inhibition
inferred← citeshttps://doi.org/10.1016/j.bmc.2018.08.028openalex-snapshot
Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2019.03.005openalex-snapshot
Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmcl.2017.12.044openalex-snapshot
Small molecule immuno-oncology therapeutic agents
inferred← citeshttps://doi.org/10.1016/j.bmcl.2018.01.032openalex-snapshot
A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies
inferred← citeshttps://doi.org/10.1016/j.bmcl.2021.127910openalex-snapshot
IDO1 and TDO inhibitory evaluation of analogues of the marine pyrroloiminoquinone alkaloids: Wakayin and Tsitsikammamines
inferred← citeshttps://doi.org/10.1016/j.bmcl.2021.128095openalex-snapshot
Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization
inferred← citeshttps://doi.org/10.1016/j.bmcl.2021.128131openalex-snapshot
WITHDRAWN: Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization
inferred← citeshttps://doi.org/10.1016/j.chembiol.2017.08.019openalex-snapshot
Small-Molecule Targets in Immuno-Oncology
inferred← citeshttps://doi.org/10.1016/j.ecoenv.2026.119774openalex-snapshot
Indoleamine 2,3-dioxygenase 1 mediated macrophage oxidative phosphorylation impairment drives pro-inflammatory M1 polarization aggravates acetaminophen-induced acute liver injury
inferred← citeshttps://doi.org/10.1016/j.ejca.2017.08.014openalex-snapshot
Challenges and perspectives in the immunotherapy of Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.05.042openalex-snapshot
Synthesis and biological evaluation of novel 2-oxo-1,2-dihydroquinoline-4-carboxamide derivatives for the treatment of esophageal squamous cell carcinoma
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113163openalex-snapshot
A theranostic probe of indoleamine 2,3-dioxygenase 1 (IDO1) for small molecule cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.114043openalex-snapshot
Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design
inferred← citeshttps://doi.org/10.1016/j.exer.2019.01.005openalex-snapshot
Investigation of indoleamine 2,3-dioxygenase 1 expression in uveal melanoma
inferred← citeshttps://doi.org/10.1016/j.gene.2018.07.003openalex-snapshot
Specific enzyme functionalities of Fusarium oxysporum compared to host plants
inferred← citeshttps://doi.org/10.1016/j.humpath.2018.09.003openalex-snapshot
Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.110429openalex-snapshot
Differentiation, regulation and function of regulatory T cells in non-lymphoid tissues and tumors
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.113253openalex-snapshot
Amino acid metabolism-related genes as potential biomarkers and the role of MATN3 in stomach adenocarcinoma: A bioinformatics, mendelian randomization and experimental validation study
inferred← citeshttps://doi.org/10.1016/j.iotech.2020.03.001openalex-snapshot
Molecular imaging for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.isci.2024.109457openalex-snapshot
TRIF-IFN-I pathway in Helicobacter-induced gastric cancer in an accelerated murine disease model and patient biopsies
inferred← citeshttps://doi.org/10.1016/j.jconrel.2020.12.019openalex-snapshot
Microneedles for painless transdermal immunotherapeutic applications
inferred← citeshttps://doi.org/10.1016/j.jid.2017.09.036openalex-snapshot
Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival
inferred← citeshttps://doi.org/10.1016/j.jormas.2024.102130openalex-snapshot
Clinicopathological and prognostic significance of indoleamine 2,3-dioxygenase (IDO) expression in head and neck squamous cell carcinoma: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.matdes.2021.109958openalex-snapshot
Review on combination strategy of immune checkpoint blockade, photodynamic therapy and nanomedicine against solid tumor
inferred← citeshttps://doi.org/10.1016/j.mehy.2022.110777openalex-snapshot
Indolamine 2,3-dioxygenase (IDO) inhibitors as a potential treatment for somatic symptoms
inferred← citeshttps://doi.org/10.1016/j.molimm.2017.11.014openalex-snapshot
Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia
inferred← citeshttps://doi.org/10.1016/j.neo.2017.12.002openalex-snapshot
A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma
inferred← citeshttps://doi.org/10.1016/j.nut.2022.111765openalex-snapshot
Potential role of tryptophan catabolism in cancer-related cognitive impairment
inferred← citeshttps://doi.org/10.1016/j.oraloncology.2021.105279openalex-snapshot
Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I/IL-6/TNF-α pathway
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2021.108055openalex-snapshot
Recent advances in clinical trials targeting the kynurenine pathway
inferred← citeshttps://doi.org/10.1016/j.trecan.2017.11.005openalex-snapshot
Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive ‘Cold’ Tumors ‘Hot’
inferred← citeshttps://doi.org/10.1016/s0007-4551(18)30397-7openalex-snapshot
Autres immunothérapies
inferred← citeshttps://doi.org/10.1021/acs.chemrev.3c00062openalex-snapshot
Tumor Abnormality-Oriented Nanomedicine Design
inferred← citeshttps://doi.org/10.1021/acs.chemrev.8b00201openalex-snapshot
Targeting Metalloenzymes for Therapeutic Intervention
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00679openalex-snapshot
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c01067openalex-snapshot
Cellular Potency Optimization of Novel Heme-Binding Imidazo[5,1- b ]thiazoles, Imidazo[1,5- a ]pyridines and Pyrazines as Potent IDO1 Inhibitors Devoid of Cytochrome P450 Inhibition
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b01809openalex-snapshot
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity
inferred← citeshttps://doi.org/10.1021/acs.jproteome.8b00803openalex-snapshot
Noninvasive Serum Metabolomic Profiling Reveals Elevated Kynurenine Pathway’s Metabolites in Humans with Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.nanolett.9b02923openalex-snapshot
A Three-in-One Immunotherapy Nanoweapon via Cascade-Amplifying Cancer-Immunity Cycle against Tumor Metastasis, Relapse, and Postsurgical Regrowth
inferred← citeshttps://doi.org/10.1021/acsami.0c15679openalex-snapshot
Electric Pulse Responsive Magnetic Nanoclusters Loaded with Indoleamine 2,3-Dioxygenase Inhibitor for Synergistic Immuno-Ablation Cancer Therapy
inferred← citeshttps://doi.org/10.1021/acsami.9b09568openalex-snapshot
Cold to Hot: Rational Design of a Minimalist Multifunctional Photo-immunotherapy Nanoplatform toward Boosting Immunotherapy Capability
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.0c00804openalex-snapshot
Nanomaterials as Smart Immunomodulator Delivery System for Enhanced Cancer Therapy
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.0c00195openalex-snapshot
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.7b00488openalex-snapshot
Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.9b00344openalex-snapshot
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1021/acsptsci.4c00265openalex-snapshot
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1
inferred← citeshttps://doi.org/10.1021/jacs.9b12232openalex-snapshot
Modularly Designed Peptide Nanoprodrug Augments Antitumor Immunity of PD-L1 Checkpoint Blockade by Targeting Indoleamine 2,3-Dioxygenase
inferred← citeshttps://doi.org/10.1038/s41392-020-00354-wopenalex-snapshot
NAD+ metabolism, stemness, the immune response, and cancer
inferred← citeshttps://doi.org/10.1038/s41416-019-0664-6openalex-snapshot
The therapeutic potential of targeting tryptophan catabolism in cancer
inferred← citeshttps://doi.org/10.1038/s41420-024-02006-2openalex-snapshot
Immunometabolism in cancer: basic mechanisms and new targeting strategy
inferred← citeshttps://doi.org/10.1038/s41467-018-05047-1openalex-snapshot
Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
inferred← citeshttps://doi.org/10.1038/s41467-022-29693-8openalex-snapshot
Bioorthogonal in situ assembly of nanomedicines as drug depots for extracellular drug delivery
inferred← citeshttps://doi.org/10.1038/s41565-025-02102-zopenalex-snapshot
Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy
inferred← citeshttps://doi.org/10.1038/s41571-019-0175-7openalex-snapshot
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
inferred← citeshttps://doi.org/10.1038/s41573-024-00974-9openalex-snapshot
Enhancing in situ cancer vaccines using delivery technologies
inferred← citeshttps://doi.org/10.1038/s41585-019-0263-6openalex-snapshot
Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
inferred← citeshttps://doi.org/10.1038/s41591-019-0404-8openalex-snapshot
The landscape of cancer cell line metabolism
inferred← citeshttps://doi.org/10.1038/s41598-018-29048-8openalex-snapshot
Novel natural killer cell-mediated cancer immunotherapeutic activity of anisomycin against hepatocellular carcinoma cells
inferred← citeshttps://doi.org/10.1038/s41598-021-85746-wopenalex-snapshot
Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
inferred← citeshttps://doi.org/10.1038/s41598-023-31007-xopenalex-snapshot
Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
inferred← citeshttps://doi.org/10.1038/s42003-023-04983-zopenalex-snapshot
Navoximod modulates local HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy via an injectable hydrogel
inferred← citeshttps://doi.org/10.1039/c9md00208aopenalex-snapshot
Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
inferred← citeshttps://doi.org/10.1039/d0cb00209gopenalex-snapshot
Design, synthesis and evaluation of tryptophan analogues as tool compounds to study IDO1 activity
inferred← citeshttps://doi.org/10.1039/d1tb02790eopenalex-snapshot
Dual-responsive nano-prodrug micelles for MRI-guided tumor PDT and immune synergistic therapy
inferred← citeshttps://doi.org/10.1039/d3bm02133eopenalex-snapshot
Nanomedicine for combination of chemodynamic therapy and immunotherapy of cancers
inferred← citeshttps://doi.org/10.1039/d3cp06036eopenalex-snapshot
A theoretical study on the activity and selectivity of IDO/TDO inhibitors
inferred← citeshttps://doi.org/10.1080/08820139.2021.1909061openalex-snapshot
Fetomaternal Immune Tolerance: Crucial Mechanisms of Tolerance for Successful Pregnancy in Humans
inferred← citeshttps://doi.org/10.1080/10715762.2024.2423690openalex-snapshot
NRF2 signaling and amino acid metabolism in cancer
inferred← citeshttps://doi.org/10.1080/13102818.2024.2421291openalex-snapshot
Investigation of IDO1 and TDO2 expression in breast tumors by immunohistochemistry and real-time polymerase chain reaction methods
inferred← citeshttps://doi.org/10.1080/13543784.2020.1793956openalex-snapshot
New immunotherapeutic drugs in advanced non-small cell lung cancer (NSCLC): from preclinical to phase I clinical trials
inferred← citeshttps://doi.org/10.1080/14712598.2021.1933940openalex-snapshot
Targeting MSS colorectal cancer with immunotherapy: are we turning the corner?
inferred← citeshttps://doi.org/10.1080/14756366.2022.2140420openalex-snapshot
Identification of the first-in-class dual inhibitors of human DNA topoisomerase IIα and indoleamine-2,3-dioxygenase 1 (IDO 1) with strong anticancer properties
inferred← citeshttps://doi.org/10.1080/17476348.2019.1623027openalex-snapshot
Combining immunotherapies to treat non-small cell lung cancer
inferred← citeshttps://doi.org/10.1080/2162402x.2018.1526250openalex-snapshot
Trial Watch: Toll-like receptor agonists in cancer immunotherapy
inferred← citeshttps://doi.org/10.1080/2162402x.2018.1562834openalex-snapshot
The density of Tbet+ tumor-infiltrating T lymphocytes reflects an effective and druggable preexisting adaptive antitumor immune response in colorectal cancer, irrespective of the microsatellite status
inferred← citeshttps://doi.org/10.1093/bfgp/ely017openalex-snapshot
Functional genomics: paving the way for more successful cancer immunotherapy
inferred← citeshttps://doi.org/10.1093/carcin/bgy088openalex-snapshot
Metabolic influence on the differentiation of suppressive myeloid cells in cancer
inferred← citeshttps://doi.org/10.1093/intimm/dxad035openalex-snapshot
Metabolic advantages of regulatory T cells dictated by cancer cells
inferred← citeshttps://doi.org/10.1093/jimmun/vkag211openalex-snapshot
Split immunomodulatory impact of leptin on human myeloid cells: key role of IDO1 in counteracting the immunostimulatory effect of leptin
inferred← citeshttps://doi.org/10.1093/neuonc/noz077openalex-snapshot
Immunotherapy for pediatric brain tumors: past and present
inferred← citeshttps://doi.org/10.1093/toxsci/kfz141openalex-snapshot
Exposure to an Environmentally Relevant Phthalate Mixture During Prostate Development Induces MicroRNA Upregulation and Transcriptome Modulation in Rats
inferred← citeshttps://doi.org/10.1097/cm9.0000000000001090openalex-snapshot
Biomarkers or factors for predicting the efficacy and adverse effects of immune checkpoint inhibitors in lung cancer: achievements and prospective
inferred← citeshttps://doi.org/10.1097/fbp.0000000000000477openalex-snapshot
The ‘Yin’ and the ‘Yang’ of the kynurenine pathway: excitotoxicity and neuroprotection imbalance in stress-induced disorders
inferred← citeshttps://doi.org/10.1097/md.0000000000019883openalex-snapshot
IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era
inferred← citeshttps://doi.org/10.1097/mou.0000000000000462openalex-snapshot
Prostate cancer immunotherapy
inferred← citeshttps://doi.org/10.1097/pas.0000000000001622openalex-snapshot
IDO1 Expression in Melanoma Metastases Is Low and Associated With Improved Overall Survival
inferred← citeshttps://doi.org/10.1097/sla.0000000000002754openalex-snapshot
IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer
inferred← citeshttps://doi.org/10.1101/2023.06.04.543598openalex-snapshot
Activation of the TRIF pathway and downstream targets results in the development of precancerous lesions during infection with Helicobacter
inferred← citeshttps://doi.org/10.1111/bcp.13961openalex-snapshot
Investigation of the absolute bioavailability and human mass balance of navoximod, a novel IDO1 inhibitor
inferred← citeshttps://doi.org/10.1111/bjd.16905openalex-snapshot
Expression profile of the amino acid transporters SLC 7A5, SLC 7A7, SLC 7A8 and the enzyme TDO 2 in basal cell carcinoma
inferred← citeshttps://doi.org/10.1111/cas.13432openalex-snapshot
Clinical significance of tryptophan catabolism in Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1111/cas.13560openalex-snapshot
High IDO ‐1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma
inferred← citeshttps://doi.org/10.1111/cas.13811openalex-snapshot
Mechanism and prognostic value of indoleamine 2,3‐dioxygenase 1 expressed in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1111/cas.14028openalex-snapshot
Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer
inferred← citeshttps://doi.org/10.1111/imr.12925openalex-snapshot
Tumor resistance mechanisms and their consequences on γδ T cell activation
inferred← citeshttps://doi.org/10.1111/liv.14192openalex-snapshot
Immune landscape of hepatocellular carcinoma microenvironment: Implications for prognosis and therapeutic applications
inferred← citeshttps://doi.org/10.1111/pin.12736openalex-snapshot
High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer
inferred← citeshttps://doi.org/10.1111/tan.13536openalex-snapshot
HLA‐G, HLA‐E, and IDO overexpression predicts a worse survival of Tunisian patients with vulvar squamous cell carcinoma
inferred← citeshttps://doi.org/10.1136/esmoopen-2019-000573openalex-snapshot
New pathways in immune stimulation: targeting OX40
inferred← citeshttps://doi.org/10.1136/lupus-2017-000254openalex-snapshot
Kynurenine pathway is altered in patients with SLE and associated with severe fatigue
inferred← citeshttps://doi.org/10.1155/2018/5068701openalex-snapshot
The Protein Expression of PDL1 Is Highly Correlated with Those of eIF2 α and ATF4 in Lung Cancer
inferred← citeshttps://doi.org/10.1155/2020/9235638openalex-snapshot
Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions
inferred← citeshttps://doi.org/10.1155/2021/6616391openalex-snapshot
T Cell Exhaustion and CAR‐T Immunotherapy in Hematological Malignancies
inferred← citeshttps://doi.org/10.1155/2022/2381018openalex-snapshot
T Lymphocyte Infiltration in Association with IDO1 Expression in Resected Lung Adenocarcinoma and Normal Adjacent Lung Tissues
inferred← citeshttps://doi.org/10.1155/2022/4446805openalex-snapshot
ZNF165 Is Involved in the Regulation of Immune Microenvironment and Promoting the Proliferation and Migration of Hepatocellular Carcinoma by AhR/CYP1A1
inferred← citeshttps://doi.org/10.1155/2023/7133726openalex-snapshot
Blockade of EP4 by ASP7657 Modulates Myeloid Cell Differentiation In Vivo and Enhances the Antitumor Effect of Radiotherapy
inferred← citeshttps://doi.org/10.1158/0008-5472.can-17-2285openalex-snapshot
Discovery of IDO1 Inhibitors: From Bench to Bedside
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-16-3001openalex-snapshot
Breast Cancer Immunotherapy: Facts and Hopes
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-18-0309openalex-snapshot
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-18-2740openalex-snapshot
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
inferred← citeshttps://doi.org/10.1158/2326-6066.cir-19-0040openalex-snapshot
Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most Cancers
inferred← citeshttps://doi.org/10.11606/d.87.2020.tde-22092023-121748openalex-snapshot
Papel da indoleamina 2,3 dioxigenase (IDO) na oncogênese e imunossupressão de tumores associados ao Papilomavírus Humano (HPV)
inferred← citeshttps://doi.org/10.1172/jci.insight.137131openalex-snapshot
Tryptophan catabolism reflects disease activity in human tuberculosis
inferred← citeshttps://doi.org/10.1172/jci.insight.154773openalex-snapshot
The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression
inferred← citeshttps://doi.org/10.1172/jci148549openalex-snapshot
Fighting in a wasteland: deleterious metabolites and antitumor immunity
inferred← citeshttps://doi.org/10.1177/0300985818808530openalex-snapshot
FoxP3 and IDO in Canine Melanocytic Tumors
inferred← citeshttps://doi.org/10.1177/0300985820960131openalex-snapshot
FoxP3, CTLA-4, and IDO in Canine Melanocytic Tumors
inferred← citeshttps://doi.org/10.1177/1178646919891736openalex-snapshot
Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937
inferred← citeshttps://doi.org/10.1177/1753466618794133openalex-snapshot
New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1
inferred← citeshttps://doi.org/10.1177/1756284818815334openalex-snapshot
Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
inferred← citeshttps://doi.org/10.1177/1758835920937902openalex-snapshot
Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies
inferred← citeshttps://doi.org/10.1186/s12885-021-08385-4openalex-snapshot
The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma – an immunohistochemical study
inferred← citeshttps://doi.org/10.1186/s12935-022-02687-8openalex-snapshot
Multimodal targeting of glioma with functionalized nanoparticles
inferred← citeshttps://doi.org/10.1186/s12935-022-02730-8openalex-snapshot
Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes
inferred← citeshttps://doi.org/10.1186/s12943-025-02460-1openalex-snapshot
Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy
inferred← citeshttps://doi.org/10.1186/s12951-026-04086-xopenalex-snapshot
Tumor-activated dual metabolic nanomodulator turns over tolerogenic tumor control and unleashes systemic immune responses
inferred← citeshttps://doi.org/10.1186/s12967-026-07758-2openalex-snapshot
IDO family: the metabolic crossroads connecting immunity, nerves and tumors
inferred← citeshttps://doi.org/10.1186/s13046-021-01847-4openalex-snapshot
What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
inferred← citeshttps://doi.org/10.1186/s13578-023-01073-9openalex-snapshot
Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms
inferred← citeshttps://doi.org/10.1186/s40364-021-00321-9openalex-snapshot
Advances in technology and applications of nanoimmunotherapy for cancer
inferred← citeshttps://doi.org/10.1360/tb-2020-0638openalex-snapshot
Cancer research driven by cutting-edge multi-disciplinary technologies
inferred← citeshttps://doi.org/10.1371/journal.pone.0321937openalex-snapshot
Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab
inferred← citeshttps://doi.org/10.15171/bi.2019.01openalex-snapshot
Indoleamine 2, 3-dioxygenase inhibitors in immunochemotherapy of breast cancer: challenges and opportunities
inferred← citeshttps://doi.org/10.15698/cst2019.09.198openalex-snapshot
Immunosurveillance of cancer cell stress
inferred← citeshttps://doi.org/10.18632/oncotarget.22190openalex-snapshot
Immune system and melanoma biology: a balance between immunosurveillance and immune escape
inferred← citeshttps://doi.org/10.18632/oncotarget.25235openalex-snapshot
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer
inferred← citeshttps://doi.org/10.18632/oncotarget.25393openalex-snapshot
Peritumoral endothelial indoleamine 2, 3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile
inferred← citeshttps://doi.org/10.21037/tlcr-20-1134openalex-snapshot
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2754183/v1openalex-snapshot
Development of Amino Acid Metabolism-Related Prognostic Model and Immune Infiltration Analysis in Patients with Stomach Adenocarcinoma
inferred← citeshttps://doi.org/10.21203/rs.3.rs-743421/v1openalex-snapshot
The Prognostic Implications of Immune Classification Using IDO1 Expression in Extrahepatic Bile Duct Carcinoma
inferred← citeshttps://doi.org/10.2147/cmar.s151023openalex-snapshot
Clinical utility of pembrolizumab in the management of advanced solid tumors: an evidence-based review on the emerging new data
inferred← citeshttps://doi.org/10.2147/dddt.s374672openalex-snapshot
Emerging Therapeutic Strategies of Different Immunotherapy Approaches Combined with PD-1/PD-L1 Blockade in Cervical Cancer
inferred← citeshttps://doi.org/10.2147/ott.s239398openalex-snapshot
Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle
inferred← citeshttps://doi.org/10.2147/ott.s581821openalex-snapshot
Enhancing Immunotherapy in Diffuse Large B-Cell Lymphoma: The Synergistic Potential of Metabolic Checkpoint Inhibitors and Immunomodulation
inferred← citeshttps://doi.org/10.2174/1386207325666220221100429openalex-snapshot
A Study on Immune Cell Infiltration in Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.2174/1574884714666190809124555openalex-snapshot
The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and Perspectives
inferred← citeshttps://doi.org/10.2174/1871520618666180910092356openalex-snapshot
Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
inferred← citeshttps://doi.org/10.2217/bmm-2018-0229openalex-snapshot
Discovering Biomarkers in Bladder Cancer by Metabolomics
inferred← citeshttps://doi.org/10.2217/fon-2019-0642openalex-snapshot
Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia
inferred← citeshttps://doi.org/10.2217/nnm-2019-0074openalex-snapshot
Nano-encapsulated Tryptanthrin Derivative for Combined Anticancer Therapy Via Inhibiting Indoleamine 2,3-dioxygenase and Inducing Immunogenic Cell Death
inferred← citeshttps://doi.org/10.26717/bjstr.2019.12.002325openalex-snapshot
Immune Markers in Non-Small Cell Lung Cancer: What Else Beyond Pd-L1 and Tumour Mutational Burden is there?
inferred← citeshttps://doi.org/10.3389/fimmu.2018.00151openalex-snapshot
The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
inferred← citeshttps://doi.org/10.3389/fimmu.2018.01598openalex-snapshot
Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2019.01720openalex-snapshot
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2020.00120openalex-snapshot
Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
inferred← citeshttps://doi.org/10.3389/fimmu.2020.00839openalex-snapshot
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool
inferred← citeshttps://doi.org/10.3389/fimmu.2020.531491openalex-snapshot
IDO Expression in Cancer: Different Compartment, Different Functionality?
inferred← citeshttps://doi.org/10.3389/fimmu.2020.601759openalex-snapshot
Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance
inferred← citeshttps://doi.org/10.3389/fimmu.2021.661357openalex-snapshot
Indoleamine 2,3-Dioxygenase 1 Inhibitor-Loaded Nanosheets Enhance CAR-T Cell Function in Esophageal Squamous Cell Carcinoma
showing the first 200 of 269 · page through all 269
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.